Princess Clark
Family · Alpharetta, GANPI 1679082549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $870, more than ten times the $59 reported in 2021.
Across 69 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$197
- AbbVie$162
- Kowa Pharmaceuticals America, Inc.$141
- Axsome Therapeutics, Inc.$114
- GSK$84
- Boston Scientific$82
- plus $634 from 19 others
What the payments were for
- Food & beverage$1,412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $197 |
| AbbVie | 8 | $162 |
| Kowa Pharmaceuticals America, Inc. | 5 | $141 |
| Axsome Therapeutics, Inc. | 4 | $114 |
| GSK | 4 | $84 |
| Boston Scientific | 3 | $82 |
| Lilly USA, LLC | 5 | $80 |
| AstraZeneca | 5 | $77 |
| Exact Sciences | 4 | $65 |
| Pfizer | 3 | $63 |
| Edwards Lifesciences | 2 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Corcept Therapeutics | 1 | $27 |
| Medtronic | 1 | $27 |
| Abbott | 1 | $23 |
| Bayer | 1 | $23 |
| Merck | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$112
How this compares
$1,412 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 19 | $169 |
| Rosuvastatin Calcium | 16 | $141 |
| Methylprednisolone | 19 | $117 |
| Omeprazole | 14 | $114 |
| Losartan Potassium | 14 | $114 |
| Doxycycline Hyclate | 15 | $101 |
| Metformin Hcl | 14 | $70 |
| Ciprofloxacin Hcl | 13 | $64 |
| Azithromycin | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Other family in Alpharetta
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.